Lipiodol Ultra Fluide

Ethyl esters of iodised fatty acids, the active ingredient in Lipiodol Ultra Fluide, is a iodinated contrast media (oil‑based) presented as a liquid for intraarterial and intralymphatic use. It provides radiopaque contrast for imaging procedures such as lymphangiography and hepatic tumor embolization.

GNH USA supplies Lipiodol Ultra Fluide as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, meeting regulatory standards and ensuring product integrity throughout the supply chain with consistent quality control.

Lipiodol Ultra Fluide, an oil‑based iodinated contrast agent, is employed in radiographic procedures that require vascular or lymphatic imaging. - Lymphangiography: Provides high‑contrast visualization of lymphatic vessels and nodes for diagnostic imaging. - Hepatic tumor embolization: Enhances radiopacity of embolic material to improve targeting of liver lesions during interventional radiology. - Vascular imaging: Supplies radiopaque contrast for intra‑arterial studies where oil‑based agents are preferred, facilitating detailed vessel assessment.

Adverse reactions to Lipiodol Ultra Fluide are generally related to its oily nature and iodine content.

Common Side Effects: - Injection site pain: mild discomfort at the site of intra‑arterial or intralymphatic administration. - Nausea or vomiting: transient gastrointestinal upset occurring shortly after the procedure. - Flushing or warmth sensation: brief feeling of warmth or skin flushing due to iodine release.

Serious or Rare Side Effects: - Allergic reaction: urticaria, bronchospasm, or anaphylaxis requiring immediate medical intervention. - Oil embolism: migration of the oily contrast into pulmonary or systemic circulation causing respiratory compromise. - Renal impairment: acute kidney injury in susceptible patients, especially with pre‑existing renal disease.

When using Lipiodol Ultra Fluide, consider the following precautions: - Pregnancy: use only if clearly needed, as safety data are limited. - Renal function: assess kidney function before administration, adjust use in impaired patients. - Allergy history: screen for iodine or contrast media hypersensitivity. - Thyroid disease: monitor thyroid function because iodine load may affect thyroid. - Concurrent embolic agents: avoid mixing with incompatible substances. - Store at ambient temperature: keep in original container, protect from light and moisture.

Lipiodol Ultra Fluide may interact with other agents as follows:

Major Interactions (Avoid): - Iodine‑containing medications: concurrent high‑dose iodine can increase risk of thyroid dysfunction. - Hyperosmolar contrast agents: co‑administration may exacerbate renal toxicity. - Thyroid hormone therapy: may amplify iodine load, affecting thyroid status.

Moderate Interactions (Monitor Closely): - Anticoagulants: oil‑based contrast may potentiate bleeding risk if embolization causes vessel injury. - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): monitor renal function when used together. - Beta‑blockers: may mask signs of contrast‑induced hypertension.